Human Matrilin-3 PharmaGenie ELISA Kit (SBRS0857)

This quantitative immunoassay targets human Matrilin-3 (MATN3), a cartilage-associated extracellular matrix protein implicated in osteoarthritis progression, chondrocyte differentiation, and inherited skeletal disorders such as multiple epiphyseal dysplasia. Researchers in connective tissue biology, rheumatology, and orthopedic science use Matrilin-3 measurements to investigate cartilage turnover, joint tissue homeostasis, and bone matrix remodeling. Assay Genie supplies the kit as a 96-test microplate format intended for research use only, accommodating absorbance-based readout workflows common to standard laboratory plate readers. The assay supports quantification in plasma-derived clinical specimens, serum samples, and conditioned media from cultured human cells, enabling both in vitro experimental work and translational studies of cartilage pathology. Each kit provides reagents sufficient for 96 assays, supporting biomarker research where Matrilin-3 levels may serve as an indicator of cartilage degradation or disease activity.